Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tumor necrosis factor: The key to hepatitis B viral clearance.

Literature DB >> 29375133

Tumor necrosis factor: The key to hepatitis B viral clearance.

I-Tsu Chyuan^1,2, Ping-Ning Hsu^3,4.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2018 PMID： 29375133 PMCID： PMC6141607 DOI： 10.1038/cmi.2017.139

Source DB: PubMed Journal: Cell Mol Immunol ISSN： 1672-7681 Impact factor: 11.530

× No keyword cloud information.

20 in total

1. Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus.

Authors: Gregor Ebert; Simon Preston; Cody Allison; James Cooney; Jesse G Toe; Michael D Stutz; Samar Ojaimi; Hamish W Scott; Nikola Baschuk; Ueli Nachbur; Joseph Torresi; Ruth Chin; Danielle Colledge; Xin Li; Nadia Warner; Peter Revill; Scott Bowden; John Silke; C Glenn Begley; Marc Pellegrini
Journal: Proc Natl Acad Sci U S A Date: 2015-04-20 Impact factor: 11.205

Review 2. Cytotoxic T cells and viral hepatitis.

Authors: F V Chisari
Journal: J Clin Invest Date: 1997-04-01 Impact factor: 14.808

Review 3. American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.

Authors: Robert P Perrillo; Robert Gish; Yngve T Falck-Ytter
Journal: Gastroenterology Date: 2014-10-31 Impact factor: 22.682

Review 4. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection.

Authors: Antonio Bertoletti; Carlo Ferrari
Journal: Gut Date: 2011-12-09 Impact factor: 23.059

5. Anti-TNF therapy in patients with HBV infection--analysis of 87 patients with inflammatory arthritis.

Authors: Hua Ye; Xue-wu Zhang; Rong Mu; Lin-kai Fang; Jie-ruo Gu; Jin Lin; Jin-feng Du; Jin-wei Chen; Yi-jia Chen; Li-jun Wu; Xue-feng Pang; Zhan-guo Li
Journal: Clin Rheumatol Date: 2014-01 Impact factor: 2.980

6. Cleaved c-FLIP mediates the antiviral effect of TNF-α against hepatitis B virus by dysregulating hepatocyte nuclear factors.

Authors: Yong Kwang Park; Eun-Sook Park; Doo Hyun Kim; Sung Hyun Ahn; Seung Hwa Park; Ah Ram Lee; Soree Park; Hong Seok Kang; Ji-Hyun Lee; Jong Man Kim; Suk-Koo Lee; Keo-Heun Lim; Nathalie Isorce; Shuping Tong; Fabien Zoulim; Kyun-Hwan Kim
Journal: J Hepatol Date: 2015-09-25 Impact factor: 25.083

7. Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection.

Authors: Li-Rung Huang; Dirk Wohlleber; Florian Reisinger; Craig N Jenne; Ru-Lin Cheng; Zeinab Abdullah; Frank A Schildberg; Margarete Odenthal; Hans-Peter Dienes; Nico van Rooijen; Edgar Schmitt; Natalio Garbi; Michael Croft; Christian Kurts; Paul Kubes; Ulrike Protzer; Mathias Heikenwalder; Percy A Knolle
Journal: Nat Immunol Date: 2013-04-14 Impact factor: 25.606

8. Immune effectors required for hepatitis B virus clearance.

Authors: Priscilla L Yang; Alana Althage; Josan Chung; Holly Maier; Stefan Wieland; Masanori Isogawa; Francis V Chisari
Journal: Proc Natl Acad Sci U S A Date: 2009-12-22 Impact factor: 11.205

9. Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.

Authors: Yuchen Xia; Daniela Stadler; Julie Lucifora; Florian Reisinger; Dennis Webb; Marianna Hösel; Thomas Michler; Karin Wisskirchen; Xiaoming Cheng; Ke Zhang; Wen-Min Chou; Jochen M Wettengel; Antje Malo; Felix Bohne; Dieter Hoffmann; Florian Eyer; Robert Thimme; Christine S Falk; Wolfgang E Thasler; Mathias Heikenwalder; Ulrike Protzer
Journal: Gastroenterology Date: 2015-09-28 Impact factor: 22.682

10. Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB.

Authors: Michael Biermer; Robyn Puro; Robert J Schneider
Journal: J Virol Date: 2003-04 Impact factor: 5.103

6 in total

Tumor necrosis factor: The key to hepatitis B viral clearance.

1. Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus.

Review 2. Cytotoxic T cells and viral hepatitis.

Review 3. American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.

Review 4. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection.

5. Anti-TNF therapy in patients with HBV infection--analysis of 87 patients with inflammatory arthritis.

6. Cleaved c-FLIP mediates the antiviral effect of TNF-α against hepatitis B virus by dysregulating hepatocyte nuclear factors.

7. Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection.

8. Immune effectors required for hepatitis B virus clearance.

9. Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.

10. Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB.

1. [Progress in interferon: A treatment of Behcet syndrome].

2. CD4⁺ T Cells Play a Critical Role in Microbiota-Maintained Anti-HBV Immunity in a Mouse Model.

3. Network pharmacology-based study on the mechanism of Yiganling capsule in hepatitis B treatment.

Review 4. The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy.

Review 5. Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice.

Review 6. Liver-Mediated Adaptive Immune Tolerance.